AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 26-50/54
EVALUATION OF THE OPTIMAL DURATION OF CHEMOTHERAPY IN PHASE-II TRIALSFOR INOPERABLE NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: LARSEN H SORENSEN JB NIELSEN AL DOMBERNOWSKY P HANSEN HH
Citation: H. Larsen et al., EVALUATION OF THE OPTIMAL DURATION OF CHEMOTHERAPY IN PHASE-II TRIALSFOR INOPERABLE NON-SMALL-CELL LUNG-CANCER (NSCLC), Annals of oncology, 6(10), 1995, pp. 993-997
IS THERE A ROLE FOR CHEMOTHERAPY OF NON-SMALL-CELL LUNG-CANCER
Authors: HANSEN HH
Citation: Hh. Hansen, IS THERE A ROLE FOR CHEMOTHERAPY OF NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 6, 1995, pp. 79-82
LONG-TERM SURVIVAL IN SMALL-CELL LUNG-CANCER - POSTTREATMENT CHARACTERISTICS IN PATIENTS SURVIVING 5 TO 18- AN ANALYSIS OF 1,714 CONSECUTIVE PATIENTS( YEARS )
Authors: LASSEN U OSTERLIND K HANSEN M DOMBERNOWSKY P BERGMAN B HANSEN HH
Citation: U. Lassen et al., LONG-TERM SURVIVAL IN SMALL-CELL LUNG-CANCER - POSTTREATMENT CHARACTERISTICS IN PATIENTS SURVIVING 5 TO 18- AN ANALYSIS OF 1,714 CONSECUTIVE PATIENTS( YEARS ), Journal of clinical oncology, 13(5), 1995, pp. 1215-1220
PROPHYLACTIC CRANIAL IRRADIATION IN SMALL-CELL LUNG-CANCER - AN UPDATE
Authors: KRISTJANSEN PEG HANSEN HH
Citation: Peg. Kristjansen et Hh. Hansen, PROPHYLACTIC CRANIAL IRRADIATION IN SMALL-CELL LUNG-CANCER - AN UPDATE, Lung cancer, 12, 1995, pp. 23-40
A HALF-MICRON CMOS LOGIC GENERATION
Authors: KOBURGER CW CLARK WF ADKISSON JW ADLER E BAKEMAN PE BERGENDAHL AS BOTULA AB CHANG W DAVARI B GIVENS JH HANSEN HH HOLMES SJ HORAK DV LAM CH LASKY JB LUCE SE MANN RW MILES GL NAKOS JS NOWAK EJ SHAHIDI G TAUR Y WHITE FR WORDEMAN MR
Citation: Cw. Koburger et al., A HALF-MICRON CMOS LOGIC GENERATION, IBM journal of research and development, 39(1-2), 1995, pp. 215-227
EUROPEAN-SCHOOL-OF-ONCOLOGY FIRST EURO-AMERICAN FORUM ON LUNG-CANCER TREATMENT
Authors: BUNN PA VANZANDWIJK N PASTORINO U AISNER J ALBERTO P ARRIAGADA R CARNEY D CORNIS R DITTRICH C GATZEMEIER U GINSBERG R GRECO FA HANSEN HH HARPER P HENRIKSSON R HUBER H KLENER P LECHEVALIER T LEWENSOHN R MURRAY N NIEDERLE N POSTMUS P ROSELL R SCAGLIOTTI G SCULIER JP SPLINTER T STAHEL R SYMANN M THATCHER N TONATO M TURRISI A
Citation: Pa. Bunn et al., EUROPEAN-SCHOOL-OF-ONCOLOGY FIRST EURO-AMERICAN FORUM ON LUNG-CANCER TREATMENT, European journal of cancer, 30A(5), 1994, pp. 710-713
EFFECT OF HIGH-DOSE DEXAMETHASONE IN CARCINOMATOUS METASTATIC SPINAL-CORD COMPRESSION TREATED WITH RADIOTHERAPY - A RANDOMIZED TRIAL
Authors: SORENSEN PS HELWEGLARSEN S MOURIDSEN H HANSEN HH
Citation: Ps. Sorensen et al., EFFECT OF HIGH-DOSE DEXAMETHASONE IN CARCINOMATOUS METASTATIC SPINAL-CORD COMPRESSION TREATED WITH RADIOTHERAPY - A RANDOMIZED TRIAL, European journal of cancer, 30A(1), 1994, pp. 22-27
SILENT PULMONARY-EMBOLISM IN PATIENTS WITH DEEP VENOUS THROMBOSIS - INCIDENCE AND FATE IN A RANDOMIZED, CONTROLLED TRIAL OF ANTICOAGULATIONVERSUS NO ANTICOAGULATION
Authors: NIELSEN HK HUSTED SE KRUSELL LR FASTING H CHARLES P HANSEN HH
Citation: Hk. Nielsen et al., SILENT PULMONARY-EMBOLISM IN PATIENTS WITH DEEP VENOUS THROMBOSIS - INCIDENCE AND FATE IN A RANDOMIZED, CONTROLLED TRIAL OF ANTICOAGULATIONVERSUS NO ANTICOAGULATION, Journal of internal medicine, 235(5), 1994, pp. 457-461
FUCOSYL-GM(1) IN SMALL-CELL LUNG-CANCER - A COMPARISON WITH THE TUMOR-MARKER NEURON-SPECIFIC ENOLASE
Authors: DRIVSHOLM L VANGSSTED A PALLESEN T HANSEN M DOMBERNOWSKY P HIRSCH F HANSEN HH
Citation: L. Drivsholm et al., FUCOSYL-GM(1) IN SMALL-CELL LUNG-CANCER - A COMPARISON WITH THE TUMOR-MARKER NEURON-SPECIFIC ENOLASE, Annals of oncology, 5(7), 1994, pp. 623-626
SINGLE-AGENT ACTIVITY OF WEEKLY GEMCITABINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
Authors: ANDERSON H LUND B BACH F THATCHER N WALLING J HANSEN HH
Citation: H. Anderson et al., SINGLE-AGENT ACTIVITY OF WEEKLY GEMCITABINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY, Journal of clinical oncology, 12(9), 1994, pp. 1821-1826
IN-VIVO INHIBITION OF ETOPOSIDE-MEDIATED APOPTOSIS, TOXICITY, AND ANTITUMOR EFFECT BY THE TOPOISOMERASE II-UNCOUPLING ANTHRACYCLINE ACLARUBICIN
Authors: HOLM B JENSEN PB SEHESTED M HANSEN HH
Citation: B. Holm et al., IN-VIVO INHIBITION OF ETOPOSIDE-MEDIATED APOPTOSIS, TOXICITY, AND ANTITUMOR EFFECT BY THE TOPOISOMERASE II-UNCOUPLING ANTHRACYCLINE ACLARUBICIN, Cancer chemotherapy and pharmacology, 34(6), 1994, pp. 503-508
OBSERVER VARIATION IN THE INTERPRETATION OF VENTILATION-PERFUSION LUNG SCINTIGRAPHY
Authors: NIELSEN HK HUSTED SE KRUSELL LR CHARLES P FASTING H HANSEN HH
Citation: Hk. Nielsen et al., OBSERVER VARIATION IN THE INTERPRETATION OF VENTILATION-PERFUSION LUNG SCINTIGRAPHY, European journal of nuclear medicine, 21(2), 1994, pp. 103-107
TREATMENT OF SMALL-CELL LUNG-CANCER - THE COPENHAGEN EXPERIENCE
Authors: HIRSCH FR DOMBERNOWSKY P HANSEN HH
Citation: Fr. Hirsch et al., TREATMENT OF SMALL-CELL LUNG-CANCER - THE COPENHAGEN EXPERIENCE, Anticancer research, 14(1B), 1994, pp. 317-319
HIGGINS,GEORGE,A., JR MD, FACS MARCH 30, 1917 SEPTEMBER 3, 1994 - OBITUARY
Authors: BUNN PA HANSEN HH
Citation: Pa. Bunn et Hh. Hansen, HIGGINS,GEORGE,A., JR MD, FACS MARCH 30, 1917 SEPTEMBER 3, 1994 - OBITUARY, Lung cancer, 11(5-6), 1994, pp. 422-422
ANTICOAGULANT-THERAPY IN DEEP VENOUS THROMBOSIS - A RANDOMIZED CONTROLLED-STUDY
Authors: NIELSEN HK HUSTED SE KRUSELL LR FASTING H CHARLES P HANSEN HH NIELSEN BO PETERSEN JB BECHGAARD P
Citation: Hk. Nielsen et al., ANTICOAGULANT-THERAPY IN DEEP VENOUS THROMBOSIS - A RANDOMIZED CONTROLLED-STUDY, Thrombosis research, 73(3-4), 1994, pp. 215-226
PROGNOSTIC IMPACT OF UROKINASE, UROKINASE RECEPTOR, AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN SQUAMOUS AND LARGE-CELL LUNG-CANCER TISSUE
Authors: PEDERSEN H BRUNNER N FRANCIS D OSTERLIND K RONNE E HANSEN HH DANO K GRONDAHLHANSEN J
Citation: H. Pedersen et al., PROGNOSTIC IMPACT OF UROKINASE, UROKINASE RECEPTOR, AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN SQUAMOUS AND LARGE-CELL LUNG-CANCER TISSUE, Cancer research, 54(17), 1994, pp. 4671-4675
TARGETING THE CYTOTOXICITY OF TOPOISOMERASE II-DIRECTED EPIPODOPHYLLOTOXINS TO TUMOR-CELLS IN ACIDIC ENVIRONMENTS
Authors: JENSEN PB SORENSEN BS SEHESTED M GRUE P DEMANT EJF HANSEN HH
Citation: Pb. Jensen et al., TARGETING THE CYTOTOXICITY OF TOPOISOMERASE II-DIRECTED EPIPODOPHYLLOTOXINS TO TUMOR-CELLS IN ACIDIC ENVIRONMENTS, Cancer research, 54(11), 1994, pp. 2959-2963
UROKINASE AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN PULMONARY ADENOCARCINOMA
Authors: PEDERSEN H GRONDAHLHANSEN J FRANCIS D OSTERLIND K HANSEN HH DANO K BRUNNER N
Citation: H. Pedersen et al., UROKINASE AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN PULMONARY ADENOCARCINOMA, Cancer research, 54(1), 1994, pp. 120-123
SERUM NEURON-SPECIFIC ENOLASE (S-NSE) IN PROGRESSIVE SMALL-CELL LUNG-CANCER (SCLC)
Authors: JORGENSEN LGM OSTERLIND K HANSEN HH COOPER EH
Citation: Lgm. Jorgensen et al., SERUM NEURON-SPECIFIC ENOLASE (S-NSE) IN PROGRESSIVE SMALL-CELL LUNG-CANCER (SCLC), British Journal of Cancer, 70(4), 1994, pp. 759-761
COMPARISON OF CLINICAL NEUROLOGICAL FUNCTION AND CT RESPONSE DURING CHEMOTHERAPY FOR INITIAL BRAIN METASTASES FROM SMALL-CELL LUNG-CANCER
Authors: SORENSEN PS KRISTJANSEN PEG WAGNER A HANSEN HH
Citation: Ps. Sorensen et al., COMPARISON OF CLINICAL NEUROLOGICAL FUNCTION AND CT RESPONSE DURING CHEMOTHERAPY FOR INITIAL BRAIN METASTASES FROM SMALL-CELL LUNG-CANCER, Acta neurologica Scandinavica, 89(5), 1994, pp. 372-377
RADICAL RADIOTHERAPY AND CHEMOTHERAPY IN LOCALIZED INOPERABLE NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED TRIAL
Authors: GREGOR A MACBETH FR PAUL J CRAM L HANSEN HH
Citation: A. Gregor et al., RADICAL RADIOTHERAPY AND CHEMOTHERAPY IN LOCALIZED INOPERABLE NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED TRIAL, Journal of the National Cancer Institute, 85(12), 1993, pp. 997-999
PROSPECTIVE EVALUATION OF THE EFFECT ON INITIAL BRAIN METASTASES FROMSMALL-CELL LUNG-CANCER OF PLATINUM-ETOPOSIDE BASED INDUCTION CHEMOTHERAPY FOLLOWED BY AN ALTERNATING MULTIDRUG REGIMEN
Authors: KRISTJANSEN PEG SORENSEN PS HANSEN MS HANSEN HH
Citation: Peg. Kristjansen et al., PROSPECTIVE EVALUATION OF THE EFFECT ON INITIAL BRAIN METASTASES FROMSMALL-CELL LUNG-CANCER OF PLATINUM-ETOPOSIDE BASED INDUCTION CHEMOTHERAPY FOLLOWED BY AN ALTERNATING MULTIDRUG REGIMEN, Annals of oncology, 4(7), 1993, pp. 579-583
A PHASE-II STUDY OF IFOSFAMIDE, CARBOPLATIN AND CISPLATIN IN ADVANCEDAND RECURRENT SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX
Authors: FILTENBORG TA HANSEN HH ENGELHOLM SA RORTH M
Citation: Ta. Filtenborg et al., A PHASE-II STUDY OF IFOSFAMIDE, CARBOPLATIN AND CISPLATIN IN ADVANCEDAND RECURRENT SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX, Annals of oncology, 4(6), 1993, pp. 485-488
NEW CYTOSTATIC DRUGS IN OVARIAN-CANCER
Authors: HANSEN HH EISENHAUER EA HANSEN M NEIJT JP PICCART MJ SESSA C THIGPEN JT
Citation: Hh. Hansen et al., NEW CYTOSTATIC DRUGS IN OVARIAN-CANCER, Annals of oncology, 4, 1993, pp. 63-70
ADVANCED EPITHELIAL OVARIAN-CANCER - 1993 CONSENSUS STATEMENTS
Authors: ALLEN DG BAAK J BELPOMME D BEREK JS BERTELSEN K HUININK WWT VANDERBURG MEL CALVERT AH CONTE PE DAUPLAT J EISENHAUER EA FAVALLI G HACKER NF HAMILTON TC HANSEN HH HANSEN M VANHOUWELINGEN HC KAYE SB LEVIN L LUND B NEIJT JP OZOLS RF PICCART MJ RUSTIN GJS SESSA C SOUTTER WP THIGPEN JT TROPE C VERMORKEN JB DEVRIES EGE
Citation: Dg. Allen et al., ADVANCED EPITHELIAL OVARIAN-CANCER - 1993 CONSENSUS STATEMENTS, Annals of oncology, 4, 1993, pp. 83-88
Risultati: 1-25 | 26-50 | 51-54